| James Adgent, MD | |
|
2131 S 17th St, Wilmington, NC 28401-7407 | |
| (910) 667-7000 | |
| (910) 815-5698 |
| Full Name | James Adgent |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 23 Years |
| Location | 2131 S 17th St, Wilmington, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023039179 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 200401159 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New Hanover Regional Medical Center | Wilmington, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Novant Health Medical Group Coastal Region Llc | 2860809936 | 412 |
News Archive
Could preventing colon cancer be as simple as developing a taste for yerba mate tea? In a recent University of Illinois study, scientists showed that human colon cancer cells die when they are exposed to the approximate number of bioactive compounds present in one cup of this brew, which has long been consumed in South America for its medicinal properties.
iCo Therapeutics Inc. (the "Company") is pleased to announce that further to its press release issued October 20, 2009 announcing a $4,000,000 brokered private placement (the "Offering") co-led by Loewen, Ondaatje, McCutcheon Limited and Versant Partners Inc. (collectively, the "Agents"), the Company has completed the first tranche of the Offering through the issuance of 6,000,000 common shares of Company (the "Shares"). The Shares were issued at a price of $0.48 per share for gross proceeds of $2,880,000.
According to the latest research lesser numbers of teenage girls and young women are getting infected by the human papillomavirus vaccine (HPV) – a virus linked to cervical cancer. Research also shows that most who start the vaccination regimen against the virus fail to take all three doses.
Myriad Genetics, Inc. today announced that clinical data from three studies with Prolaris in prostate cancer patients will be highlighted at the 2014 Society of Urologic Oncology Annual Meeting being held tomorrow in Rockville, Md. The new data show that the Prolaris test could save the healthcare system $6 billion over 10 years and that physicians are using the test appropriately to personalize treatment options for their patients.
Valeant Pharmaceuticals International, Inc. today announced that the Company's Board of Directors (the "Board") has declared a one-time special dividend of US$1.00 per common share (the "Special Dividend") that shareholders of record as of the close of business on November 15, 2010 (the "Record Date") will be entitled to receive on December 22, 2010.
› Verified 2 days ago
| Entity Name | Novant Health Medical Group Coastal Region Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649865791 PECOS PAC ID: 2860809936 Enrollment ID: O20210408000285 |
News Archive
Could preventing colon cancer be as simple as developing a taste for yerba mate tea? In a recent University of Illinois study, scientists showed that human colon cancer cells die when they are exposed to the approximate number of bioactive compounds present in one cup of this brew, which has long been consumed in South America for its medicinal properties.
iCo Therapeutics Inc. (the "Company") is pleased to announce that further to its press release issued October 20, 2009 announcing a $4,000,000 brokered private placement (the "Offering") co-led by Loewen, Ondaatje, McCutcheon Limited and Versant Partners Inc. (collectively, the "Agents"), the Company has completed the first tranche of the Offering through the issuance of 6,000,000 common shares of Company (the "Shares"). The Shares were issued at a price of $0.48 per share for gross proceeds of $2,880,000.
According to the latest research lesser numbers of teenage girls and young women are getting infected by the human papillomavirus vaccine (HPV) – a virus linked to cervical cancer. Research also shows that most who start the vaccination regimen against the virus fail to take all three doses.
Myriad Genetics, Inc. today announced that clinical data from three studies with Prolaris in prostate cancer patients will be highlighted at the 2014 Society of Urologic Oncology Annual Meeting being held tomorrow in Rockville, Md. The new data show that the Prolaris test could save the healthcare system $6 billion over 10 years and that physicians are using the test appropriately to personalize treatment options for their patients.
Valeant Pharmaceuticals International, Inc. today announced that the Company's Board of Directors (the "Board") has declared a one-time special dividend of US$1.00 per common share (the "Special Dividend") that shareholders of record as of the close of business on November 15, 2010 (the "Record Date") will be entitled to receive on December 22, 2010.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Adgent, MD Po Box 936857, Atlanta, GA 31193-6857 Ph: () - | James Adgent, MD 2131 S 17th St, Wilmington, NC 28401-7407 Ph: (910) 667-7000 |
News Archive
Could preventing colon cancer be as simple as developing a taste for yerba mate tea? In a recent University of Illinois study, scientists showed that human colon cancer cells die when they are exposed to the approximate number of bioactive compounds present in one cup of this brew, which has long been consumed in South America for its medicinal properties.
iCo Therapeutics Inc. (the "Company") is pleased to announce that further to its press release issued October 20, 2009 announcing a $4,000,000 brokered private placement (the "Offering") co-led by Loewen, Ondaatje, McCutcheon Limited and Versant Partners Inc. (collectively, the "Agents"), the Company has completed the first tranche of the Offering through the issuance of 6,000,000 common shares of Company (the "Shares"). The Shares were issued at a price of $0.48 per share for gross proceeds of $2,880,000.
According to the latest research lesser numbers of teenage girls and young women are getting infected by the human papillomavirus vaccine (HPV) – a virus linked to cervical cancer. Research also shows that most who start the vaccination regimen against the virus fail to take all three doses.
Myriad Genetics, Inc. today announced that clinical data from three studies with Prolaris in prostate cancer patients will be highlighted at the 2014 Society of Urologic Oncology Annual Meeting being held tomorrow in Rockville, Md. The new data show that the Prolaris test could save the healthcare system $6 billion over 10 years and that physicians are using the test appropriately to personalize treatment options for their patients.
Valeant Pharmaceuticals International, Inc. today announced that the Company's Board of Directors (the "Board") has declared a one-time special dividend of US$1.00 per common share (the "Special Dividend") that shareholders of record as of the close of business on November 15, 2010 (the "Record Date") will be entitled to receive on December 22, 2010.
› Verified 2 days ago
Li Nichols, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2131 S 17th St, Wilmington, NC 28401 Phone: 910-667-7000 Fax: 910-815-5698 | |
Benjamin Todd Freasier, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2131 S 17th St, Wilmington, NC 28401 Phone: 910-667-7000 Fax: 910-815-5698 | |
Dr. Oyakhire C Ofori, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1202 Medical Center Dr, Wilmington, NC 28401 Phone: 910-343-7000 Fax: 910-667-7908 | |
Udoaku Eberechuckwu Lintula, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2131 S 17th St, Wilmington, NC 28401 Phone: 910-815-5830 | |
Prasheen Piyush Shah, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1202 Medical Center Dr, Wilmington, NC 28401 Phone: 910-341-3300 Fax: 910-251-2067 | |
Dr. Stephen Keith Funkhouser, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1202 Medical Center Drive, Attn: Credentialing, Wilmington, NC 28401 Phone: 910-341-3300 Fax: 910-251-2067 |